Back to Search
Start Over
P-088: Indirubin-3'-monoxime acts as an alternative proteasome inhibitor and confers new regimens for the treatment of Multiple Myeloma.
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 2, Vol. 21, pS87-S87, 1p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 21
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 153495123
- Full Text :
- https://doi.org/10.1016/S2152-2650(21)02222-9